Combined company named Aebi Schmidt Group Trading on NASDAQ expected to begin July 1, 2025 Shyft common stock delisted from Nasdaq The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft”), the North American leader in specialty vehicle manufacturing, assembly, and upfit for the commercial, retail, and service markets, today announced the successful completion of the previously announced […]

Sheffield, South Yorkshire, United Kingdom, July 01, 2025 (GLOBE NEWSWIRE) — TWL Miner, a UK-based cloud mining platform established in 2019, has announced the successful completion of its Series B funding round, securing $95 million to support the integration of artificial intelligence technologies into its cloud mining operations. The funding round included participation from multiple

(NYSE:CMRE),(NYSE:CMRE-PB),(NYSE:CMRE-PC),(NYSE:CMRE-PD), MONACO, July 01, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”) (NYSE: CMRE PR B), US $0.531250 per share on its 8.50% Series C Cumulative Redeemable Perpetual Preferred

(NASDAQ:ABEO), CLEVELAND, July 01, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, has exercised its option to license Abeona's patented AAV204 capsid for use in potential gene therapies for a range of prevalent and rare retinal diseases that result in

(TSX-V:DGHI),(NASDAQ:DGHI),(NASDAQ:DGXX),(TSX-V:DGX),(NASDAQ:SMCI),(NASDAQ:NNE), This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025 MIAMI, July 01, 2025 (GLOBE NEWSWIRE) — Digi Power X Inc. (“Digi Power X” or the “Company“) (Nasdaq: DGXX / TSXV: DGX), an

(NASDAQ:CGTX), PURCHASE, N.Y., July 01, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 'START' Study surpasses 50% enrollment. The START Study is being conducted with partners at the Alzheimer's Clinical Trials Consortium (ACTC), with $81

(NASDAQ:ADPT), SEATTLE, July 01, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point-of-care solutions in oncology, today

(NasdaqGM:FINW), MURRAY, Utah, July 01, 2025 (GLOBE NEWSWIRE) — FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), the parent company of FinWise Bank, today announced that it will report its second quarter 2025 results and host a conference call and webcast after the market close on Thursday, July 24, 2025. Conference Call Information The conference

(NYSE:SON), HARTSVILLE, S.C., July 01, 2025 (GLOBE NEWSWIRE) — Sonoco Products Company (“Sonoco” or the “Company”)(NYSE: SON), a global leader in high-value sustainable packaging, will announce second quarter 2025 results on Wednesday, July 23, 2025, after the market closes. The Company will host a conference call to discuss these results on Thursday, July 24, 2025,

(NYSE:WSO), MIAMI, July 01, 2025 (GLOBE NEWSWIRE) — Watsco, Inc.'s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $3.00 on each outstanding share of its Common and Class B common stock payable on July 31, 2025 to shareholders of record at the close of business on July 16, 2025. Watsco